Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-19

Clinical Trial Update: Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") [Phase 2]

View source ↗

Summary

Phase 2 trial comparing standard chemotherapy plus enzastaurin versus placebo in ovarian cancer; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enzastaurin (enzastaurin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Ovarian Cancer, Fallopian Tube Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2020-10-19